Literature DB >> 26783235

MicroRNA‑451 inhibits neuroblastoma proliferation, invasion and migration by targeting macrophage migration inhibitory factor.

Geng Liu1, Zhengwei Xu2, Dingjun Hao2.   

Abstract

Neuroblastoma (NB) is the most prevalent type of extracranial solid tumour in young children. To improve current understanding of the mechanisms, which modulate cancer cell proliferation, invasion and migration, investigations have focused on microRNAs (miRs), a class of small non‑coding RNAs, which post‑transcriptionally regulate gene expression during various crucial cell processes. The present study aimed to investigate the role of miR‑451 in NB. Human NB tissue and adjacent normal tissue were surgically removed, and the expression of miR‑451, and development and pathological characteristics of NB were investigated. The expression of miR‑451 was reduced in the NB tissue, compared with that in the adjacent tissue, and correlations between the reduction in miR‑451 and unfavourable variables included tumour size (P=0.0081), differentiation (P=0.0217), lymph node metastasis (P=0.0489), tumour‑node‑metastasis stage (0.0220) and distant metastases (P=0.0201). Transfection of the SK‑N‑SH and GI‑LA‑N NB cell lines with miR‑451 inhibited cell growth, invasion and migration. Furthermore, the present study demonstrated that macrophage migration inhibitory factor (MIF) was regulated directly by miR‑451 and was a critical mediator of the biological effects of miR‑451 in NB. The re‑expression of MIF markedly reversed the carcinogenic inhibitory property of miR‑451. These data provide a more detailed understanding of the essential role of miR‑451 in NB, which relies on regulation of the expression of MIF.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26783235     DOI: 10.3892/mmr.2016.4770

Source DB:  PubMed          Journal:  Mol Med Rep        ISSN: 1791-2997            Impact factor:   2.952


  12 in total

Review 1.  Inflammatory MicroRNAs and the Pathophysiology of Endometriosis and Atherosclerosis: Common Pathways and Future Directions Towards Elucidating the Relationship.

Authors:  Zubeen D Azari; Fatimah Aljubran; Warren B Nothnick
Journal:  Reprod Sci       Date:  2022-04-27       Impact factor: 2.924

2.  S-trityl-L-cysteine, a novel Eg5 inhibitor, is a potent chemotherapeutic strategy in neuroblastoma.

Authors:  Wei Wu; Shao Jingbo; Weijue Xu; Jiangbin Liu; Yiming Huang; Qingfeng Sheng; Zhibao Lv
Journal:  Oncol Lett       Date:  2018-05-21       Impact factor: 2.967

3.  MiR-20a-5p suppresses tumor proliferation by targeting autophagy-related gene 7 in neuroblastoma.

Authors:  Yongbo Yu; Jie Zhang; Yaqiong Jin; Yeran Yang; Jin Shi; Feng Chen; Shujing Han; Ping Chu; Jie Lu; Huanmin Wang; Yongli Guo; Xin Ni
Journal:  Cancer Cell Int       Date:  2018-01-04       Impact factor: 5.722

4.  MicroRNA-33b inhibits cell proliferation and glycolysis by targeting hypoxia-inducible factor-1α in malignant melanoma.

Authors:  Yue Zhao; Cuiling Wu; Lina Li
Journal:  Exp Ther Med       Date:  2017-06-28       Impact factor: 2.447

Review 5.  Tumor-Associated Macrophages in Oncolytic Virotherapy: Friend or Foe?

Authors:  Nicholas L Denton; Chun-Yu Chen; Thomas R Scott; Timothy P Cripe
Journal:  Biomedicines       Date:  2016-07-07

6.  Molecular Events Controlling Cessation of Trunk Neural Crest Migration and Onset of Differentiation.

Authors:  Vivian M Lee; Sergio Hernandez; Belle Giang; Chris Chabot; Jazmir Hernandez; Maria Elena de Bellard
Journal:  Front Cell Dev Biol       Date:  2020-04-02

7.  Macrophage Migration Inhibitory Factor and microRNA-451a in Response to Mindfulness-based Therapy or Treatment as Usual in Patients with Depression, Anxiety, or Stress and Adjustment Disorders.

Authors:  Xiao Wang; Kristina Sundquist; Karolina Palmér; Anna Hedelius; A A Memon; Jan Sundquist
Journal:  Int J Neuropsychopharmacol       Date:  2018-06-01       Impact factor: 5.176

Review 8.  Personalized regulation of glioblastoma cancer stem cells based on biomedical technologies: From theory to experiment (Review).

Authors:  Igor Bryukhovetskiy; Arina Ponomarenko; Irina Lyakhova; Sergey Zaitsev; Yulia Zayats; Maria Korneyko; Marina Eliseikina; Polina Mischenko; Valerie Shevchenko; Hari Shanker Sharma; Aruna Sharma; Yuri Khotimchenko
Journal:  Int J Mol Med       Date:  2018-05-10       Impact factor: 4.101

Review 9.  Emerging Role of the Macrophage Migration Inhibitory Factor Family of Cytokines in Neuroblastoma. Pathogenic Effectors and Novel Therapeutic Targets?

Authors:  Eugenio Cavalli; Rosella Ciurleo; Maria Cristina Petralia; Paolo Fagone; Rita Bella; Katia Mangano; Ferdinando Nicoletti; Placido Bramanti; Maria Sofia Basile
Journal:  Molecules       Date:  2020-03-06       Impact factor: 4.411

10.  MicroRNAs in neuroblastoma tumorigenesis, therapy resistance, and disease evolution.

Authors:  Natarajan Aravindan; Karthikeyan Subramanian; Dinesh Babu Somasundaram; Terence S Herman; Sheeja Aravindan
Journal:  Cancer Drug Resist       Date:  2019-12-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.